We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Performance Study of Newly Developed Ostomy Products

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01513330
First Posted: January 20, 2012
Last Update Posted: January 9, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Coloplast A/S
  Purpose
The purpose of the study is to evaluate leakage of a newly developed ostomy product compared to standard care in subjects with colostomies. Subjects will be asked to use each test product for 2 weeks - in total, the study period is 4 weeks and the hypothesis is to show that the newly developed ostomy product is significantly better to reduce leakage compared to standard care.

Condition Intervention Phase
Stoma Colostomy Device: SenSura Mio Device: Standard Care Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: An Open-labelled, Randomised, Controlled, Crossover Investigation Evaluating Performance of a Newly Developed Ostomy Care Product Compared to Standard Care.

Resource links provided by NLM:


Further study details as provided by Coloplast A/S:

Primary Outcome Measures:
  • Degree of Leakage. Each Baseplate Can Have a Score From 0-24 Points Were 0 is the Best Possible Outcome (No Leakage) and 24 Points is the Worst Possible Outcome (Full Plate Leakage) [ Time Frame: 14 days ]
    Degree of leakage will be measured by a 25-point leakage scale (no leakage or up till 24 points of leakage), developed by Coloplast A/S. The subjects receive Petri dishes with pre-printed leakage scale on. The subject will place the Petri dish above the used baseplate and indicate where on the baseplate output appears. This is done by ticking of each area on the scale indicating the area of leakage.


Enrollment: 122
Study Start Date: November 2011
Study Completion Date: August 2012
Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: First Standard Care, then SenSura Mio
Subjects first test Standard Care (Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima) and after cross-over SenSura Mio
Device: SenSura Mio
Ostomy product - 1 piece closed bag
Device: Standard Care
Ostomy product 1 piece closed bags. Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima.
Experimental: First SenSura Mio, then Standard Care
Subjects first test SenSura Mio and after cross-over Standard Care(Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima)
Device: SenSura Mio
Ostomy product - 1 piece closed bag
Device: Standard Care
Ostomy product 1 piece closed bags. Either SenSura, Nova 1, Moderna/Moderna Flex, Esteem or Flexima/Softima.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Have given written informed consent.
  2. Be at least 18 years of age and have full legal capacity.
  3. Have experienced leakage under the base plate at least once a week over the last two weeks.
  4. Be able to handle the bags themselves or with help from caregiver (e.g. spouse).
  5. Have a colostomy with a diameter between 20 and 45 mm.
  6. Have had their ostomy for at least three months.
  7. Currently use a 1-piece flat product with closed bag.
  8. Use minimum 1 product per day.
  9. Be suitable for participation in the investigation and for using a standard adhesive, flat base plate (evaluated by investigator).

Exclusion Criteria:

  1. Use irrigation during the study (flush the stoma with water).
  2. Currently receiving or have within the past 2 months received radio- and/or chemotherapy.
  3. Currently receiving or have within the past month received local or systemic steroid treatment in the peristomal area.
  4. Are pregnant or breastfeeding.
  5. Participating in other interventional clinical investigations or have previously participated in this investigation.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01513330


Locations
Germany
Publicare
Cologne, Køln, Germany
Sponsors and Collaborators
Coloplast A/S
Investigators
Principal Investigator: Wenche Sundberg, stoma nurse Diakonhjemmet Sykhus, Oslo
Principal Investigator: Merete Bjørke, Stoma Nurse St. Olavs Hopsital
Principal Investigator: Vigids Dagsland, Stoma Nurse Haugesund Sykhus
Principal Investigator: Randi Melum, Stoma Nurse St. Olavs Hospital
  More Information

Responsible Party: Coloplast A/S
ClinicalTrials.gov Identifier: NCT01513330     History of Changes
Other Study ID Numbers: CP219
First Submitted: January 10, 2012
First Posted: January 20, 2012
Results First Submitted: August 6, 2013
Results First Posted: January 9, 2014
Last Update Posted: January 9, 2014
Last Verified: November 2013